FIRST MANHATTAN CO. LLC. - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,056
-84.6%
11,1750.0%0.00%
Q2 2023$13,354
+72.9%
11,1750.0%0.00%
Q1 2023$7,724
-19.7%
11,175
-21.2%
0.00%
Q4 2022$9,624
-31.3%
14,1750.0%0.00%
Q3 2022$14,000
-12.5%
14,175
-43.2%
0.00%
Q2 2022$16,000
-11.1%
24,967
+13.7%
0.00%
Q1 2022$18,000
-48.6%
21,9670.0%0.00%
Q4 2021$35,000
-32.7%
21,9670.0%0.00%
Q3 2021$52,000
-8.8%
21,9670.0%0.00%
Q2 2021$57,000
-5.0%
21,967
+80.5%
0.00%
Q1 2021$60,00012,1720.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders